Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,387.60 +52.30 0.34%
S&P 500 1,669.16 +2.87 0.17%
Nasdaq 3,502.12 +5.69 0.16%
Ticker Volume Price Price Delta
STOXX 50 2,812.48 -9.17 -0.32%
FTSE 100 6,800.02 -3.85 -0.06%
DAX 8,460.00 -12.20 -0.14%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Exchange: -
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

MAP Pharmaceuticals Inc

MAPP:US

Acquired

Company Profile for MAP Pharmaceuticals Inc (MAPP)

MAP Pharmaceuticals Inc. is a biopharmaceutical company. The Company develops treatments for respiratory and CNS diseases.

Contact Information

MAP Pharmaceuticals Inc

2400 Bayshore Parkway
Suite 200
Mountain View, CA 94043
United States
Phone: 1-650-386-3100
Fax: 1-650-386-3101

Key Executives for MAP Pharmaceuticals Inc (MAPP)

Scott R WardChairmanTimothy S NelsonPresident/CEO
Thomas A ArmerChief Scientific OfficerChristopher Y ChaiSenior VP/CFO
Anastasios E GianakakosSenior VP/Chief Business OfcrCharlene Andros FriedmanSenior VP/Secretary/Gen Cnsl
Donald J KellermanSenior VP:Clinical DevptScott W BorlandSenior VP:Neurology Franchise

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil